4G Clinical
4G Clinical provides subscription-based randomization and trial supply management (RTSM) software, anchored by its Prancer RTSM® platform. It serves more than 100 biotech and pharma clients globally, including biotechs, CROs, and large pharmaceutical companies.
- Company typePrivate
- Founded2016
- HeadquartersWellesley, United States
- Headcount251–500
- GTM typeB2B
- OfferingSoftware
What 4G Clinical does
4G Clinical is a Wellesley, Massachusetts-based software company that provides randomization and trial supply management (RTSM) technology for clinical drug trials. Its core platform, Prancer RTSM®, unifies randomization, supply management, and study oversight in a single operational environment, keeping patient dosing, supply movement, and forecasting connected to real-time study activity. The product suite is complemented by 4C Supply® for forecasting and scenario modeling, Prancer Lite® for simpler trial requirements, Ultima Rand® for randomization, and the Enterprise Prancer Integrations (EPI) framework for sponsor-level program governance. The company serves over 100 biotech and pharma clients globally, with horizontal segmentation across small and mid-size biotechs, contract research organizations (CROs), and large enterprise pharmaceutical companies.
4G Clinical operates a subscription-based enterprise SaaS model on multi-year contracts, with quote-based pricing and dedicated delivery specialists engaged from study kickoff through closeout. Go-to-market is direct enterprise sales supported by content marketing (blog, white papers, podcasts, webinars), industry events, and LinkedIn presence. The company holds filed/pending patents related to clinical trial randomization and supply management technology and markets itself on operational continuity, governed amendment pathways, and supply forecasting matched to protocol design.
The company was co-founded by David Kelleher (CEO) and Ed Tourtellotte (Board Director). In mid-2021, it closed a $230 million growth equity investment from Goldman Sachs Asset Management to fund global expansion, product development, and team growth. In August 2024, Dr. Ronan Brown was appointed as Chief Operating Officer, indicating continued organizational scaling. Headcount sits in the 251–500 range, and the company claims global delivery across multiple countries.
4G Clinical firmographics
Firmographics- Name
- 4G Clinical
- Legal name
- 4G Clinical
- Website
- https://4gclinical.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- 4G Clinical provides subscription-based randomization and trial supply management (RTSM) software, anchored by its Prancer RTSM® platform. It serves more than 100 biotech and pharma clients globally, including biotechs, CROs, and large pharmaceutical companies.
- Ownership category
- akta.pro rank
4G Clinical industry classification
Industry- Product category
- Clinical Trial Software (RTSM)
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Randomization & Trial Supply Management (RTSM/IRT/IVRS/IWRS) (HLACAOAC)
- akta.pro secondary industry
- Point-of-Care & Decentralized Trial Testing Services (HLAGAEAK)
Keywords
Where 4G Clinical is headquartered
LocationHeadquarters
- HQ city
- Wellesley
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
4G Clinical business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Software Subscription (RTSM): SaaS-based randomization and trial supply management software delivered as subscription service with dedicated delivery and specialist support throughout the study lifecycle.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Enterprise RTSM solutions with dedicated support |
Distribution channels1 record
Marketing channels7 records
4G Clinical product offering
Product offeringCore offering
4G Clinical sells cloud-based Randomization and Trial Supply Management (RTSM) software, led by its Prancer RTSM® platform that unifies randomization, supply management, and study oversight for live clinical trial execution. The company complements this with 4C Supply® for forecasting and scenario modeling, Prancer Lite® for simpler trial designs, EPI integration framework, and Ultima Rand® randomization technology, all delivered as a SaaS subscription with dedicated specialist teams supporting biotech, CRO, and pharma customers globally.
Product overview
4G Clinical delivers randomization and trial supply technology built for complex clinical trials. The core offering is Prancer RTSM®, which unifies randomization, supply management, and study oversight within a single operational environment. This is complemented by 4C Supply® for broader forecasting, scenario modelling, and long-range planning, as well as Prancer Lite® for studies with more streamlined requirements. Enterprise Prancer Integrations (EPI) provide a connectivity framework for scalable deployment across programs. The product suite supports over 100 biotech and pharma clients in global clinical trials.
Differentiator
Problem solved
Functional benefit
Brands
- Prancer RTSM®: Flexible Randomization and Trial Supply Management solution that unifies randomization, supply management, and study oversight for more aligned trial execution.
- Prancer Lite®
- 4C Supply®
- Ultima Rand®
- Enterprise Prancer Integrations (EPI)
Products and services
- Prancer RTSM® Cloud-based Randomization and Trial Supply Management (RTSM) platform that unifies randomization, supply, and forecasting for live clinical trial execution. It keeps patient dosing, supply movement, and oversight connected to real-time study activity for biotechs, CROs, and large pharma sponsors.
- 4C Supply® Forecasting, scenario modeling, and supply oversight solution aligned to changing study demand, supporting min/max models through predictive and dynamic demand forecasting for clinical trial supply chains.
- Prancer Lite® Lighter, simplified version of the Prancer RTSM platform for clinical studies with more streamlined randomization and supply requirements, typically used by smaller biotechs.
- Ultima Rand® Supporting randomization technology that powers randomization capabilities within 4G Clinical's product ecosystem.
Quantifiable outcome
- Supports clinical trials across multiple countries with global delivery experience
- +1 more outcomes
Companies that use 4G Clinical
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
4G Clinical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
4G Clinical partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights5 records
4G Clinical competitors and assessment
Company assessmentDirect peers
- Suvoda: Suvoda is a purpose-built IRT/RTSM specialist serving biotech and pharma sponsors with similar randomization, supply management, and eClinical workflows. It is the closest direct competitor to 4G Clinical's Prancer RTSM offering.
- Endpoint Clinical: Endpoint Clinical (now part of the Clinical ink / broader portfolio) specializes in RTSM/IRT and interactive response technology for clinical trials. It targets similar biotech and pharma customers with comparable randomization and drug supply management functionality.
- Signant Health: Signant Health provides RTSM alongside eCOA, eConsent, and patient engagement solutions for clinical trials. It directly competes with 4G Clinical in the randomization and trial supply management category, serving overlapping biotech and pharma customers.
- Clario: Clario delivers RTSM/IRT, eCOA, imaging, and respiratory solutions for clinical trials. Following its combination with Bioclinica, Clario operates as a scaled direct competitor across many of 4G Clinical's target use cases.
- YPrime: YPrime provides eCOA, IRT/RTSM, and clinical trial technology with a focus on flexibility and patient-centric trial design. It serves the same biotech, CRO, and pharma customer segments as 4G Clinical with comparable RTSM functionality.
- Almac Group: Almac offers IXRS/IRT technology alongside clinical trial supply services, providing end-to-end randomization and supply chain solutions. It overlaps directly with 4G Clinical's RTSM and 4C Supply offerings, often competing for the same sponsor programs.
Broad incumbents
- Medidata Solutions: Medidata (a Dassault Systèmes company) offers Rave RTSM as part of its industry-leading unified clinical trial platform spanning EDC, eCOA, and CTMS. It is a broad incumbent with deep enterprise pharma penetration and a major competitive force for 4G Clinical.
- Oracle Health Sciences (Clinical One): Oracle's Clinical One platform includes randomization and trial supply management capabilities integrated with EDC and CTMS. As a broad enterprise software incumbent, it competes with 4G Clinical especially for enterprise pharma deployments.
- Veeva Systems: Veeva Vault RTSM extends Veeva's life sciences cloud platform into randomization and trial supply management. Veeva is a broad incumbent with strong relationships across enterprise pharma, creating bundling pressure for 4G Clinical.
- IQVIA: IQVIA is a global CRO and clinical technology provider offering RTSM as part of its broader eClinical suite. As a broad incumbent with deep pharma relationships and CRO services, it competes with 4G Clinical especially in integrated RTSM-plus-CRO engagements.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
4G Clinical social profiles
Digital presence4G Clinical financial estimates
Financial estimateRevenue estimate
Valuation estimate
4G Clinical leadership team
Management profileNumber of profiles
Profiles3 records
4G Clinical funding detail
Funding detailFunding overview
Funding rounds4 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
4G Clinical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about 4G Clinical
What does 4G Clinical do?
4G Clinical sells cloud-based Randomization and Trial Supply Management (RTSM) software, led by its Prancer RTSM® platform that unifies randomization, supply management, and study oversight for live clinical trial execution. The company complements this with 4C Supply® for forecasting and scenario modeling, Prancer Lite® for simpler trial designs, EPI integration framework, and Ultima Rand® randomization technology, all delivered as a SaaS subscription with dedicated specialist teams supporting biotech, CRO, and pharma customers globally.
Is 4G Clinical a public or private company?
4G Clinical is a private company. It is classified as venture growth investor backed and is currently operating.
When was 4G Clinical founded?
4G Clinical was founded in 2016. It employs 251 to 500 people.
Where is 4G Clinical based?
4G Clinical is headquartered in Wellesley, United States, in the North America region.
How does 4G Clinical make money?
One revenue line is on record: software Subscription (RTSM).
Who are 4G Clinical's main competitors?
Direct peers on record are Suvoda, Endpoint Clinical, Signant Health, Clario, YPrime and Almac Group. Broad incumbents are Medidata Solutions, Oracle Health Sciences (Clinical One), Veeva Systems and IQVIA.
Does 4G Clinical have an API?
No public API is recorded for 4G Clinical.
What industry is 4G Clinical in?
4G Clinical's product category is Clinical Trial Software (RTSM). Its primary akta.pro industry code is HLACAOAC, Randomization & Trial Supply Management (RTSM/IRT/IVRS/IWRS), with a secondary code of HLAGAEAK, Point-of-Care & Decentralized Trial Testing Services. Its NAICS code is 5132 and its SIC code is 7372.